1. Home
  2. XRAY vs PGEN Comparison

XRAY vs PGEN Comparison

Compare XRAY & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

HOLD

Current Price

$11.63

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.14

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRAY
PGEN
Founded
1899
1998
Country
United States
United States
Employees
N/A
47
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
XRAY
PGEN
Price
$11.63
$6.14
Analyst Decision
Hold
Buy
Analyst Count
14
5
Target Price
$14.58
$8.33
AVG Volume (30 Days)
5.2M
5.2M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
5.58%
N/A
EPS Growth
33.04
N/A
EPS
0.14
0.03
Revenue
N/A
$230,981,000.00
Revenue This Year
N/A
$1,115.92
Revenue Next Year
$2.06
$81.04
P/E Ratio
$82.71
$215.33
Revenue Growth
N/A
N/A
52 Week Low
$9.41
$2.62
52 Week High
$14.86
$7.32

Technical Indicators

Market Signals
Indicator
XRAY
PGEN
Relative Strength Index (RSI) 42.32 52.22
Support Level $10.96 $3.44
Resistance Level $12.01 N/A
Average True Range (ATR) 0.65 0.42
MACD -0.32 -0.02
Stochastic Oscillator 16.46 45.85

Price Performance

Historical Comparison
XRAY
PGEN

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: